Company intelligence / Profile preview

22nd Century Group

Buffalo, New York, United Statesxxiicentury.com ↗

Ownership: Public · XXII
Development stage: Commercial

Overview

22nd Century Group developed the first FDA-authorized Modified Risk Tobacco Product (MRTP) combustible cigarette—VLN®—with ~95% less nicotine than conventional cigarettes. Clinical studies show VLN® can help reduce daily cigarette consumption by over a third. The company’s proprietary plant biotechnology platform enables precise control of nicotine levels in tobacco and has been validated through regulatory approval and commercial launch across thousands of retail locations.[1][2][8] Hemp/cannabis R&D was discontinued after divestiture of GVB Biopharma subsidiary in December 2023.[10]

Therapeutic areas: Psychiatry
Modalities: Small moleculesPlant-derived compounds
Industry: Non-Drug Biotech

Drug pipeline

1 asset

VLN

Commercial

Indications: Smoking cessation, Nicotine addiction

Partnerships

Collaborative research agreements with North Carolina State University, University of Kentucky, KeyGene, National Institute on Drug Abuse/FDA-funded studies[6][10].

Beyond the preview

Go deeper on 22nd Century Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 22nd Century Group.

Explore the full profile